Clinical Study of "Regenerative Medicine Using iPS Cell-Derived Neural Progenitor Cells for Subacute Spinal Cord Injury" (Cell Transplantation Performed on the First Patient)

Publish: January 14, 2022

Public Relations Office

2022/01/14

午夜剧场 School of Medicine

午夜剧场 Hospital

Japan Agency for Medical Research and Development

午夜剧场 Hospital has transplanted human iPS cell-derived neural progenitor cells into the first patient in the clinical study of "Regenerative Medicine Using iPS Cell-Derived Neural Progenitor Cells for Subacute Spinal Cord Injury."

Please see below for the full press release.

Press Release (PDF)

Press Release